Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash from Financing Activities of -$144.0 million for Q2 2026, down 24.14% year-over-year from -$189.8 million in Q2 2025, and up 35.14% sequentially from -$222.0 million in Q1 2026.
Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$144.0 million for Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 24.14% year-over-year to -$144.0 million; the trailing twelve-month figure through Apr 2026 stood at -$785.0 million (down 51.84% YoY), and the FY2025 full-year result was -$715.0 million, up 4.92% from the prior year.
- Cash from Financing Activities was -$144.0 million for Q2 2026 at Agilent Technologies, up from -$222.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $25.0 million in Q4 2024 and troughed at -$546.0 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is -$220.5 million (2025), against an average of -$229.7 million.
- On a YoY basis, Cash from Financing Activities climbed as much as 112.44% in 2024 and fell as far as 1311.76% in 2024.
- Year by year, Cash from Financing Activities stood at -$341.0 million in 2022, then surged by 41.06% to -$201.0 million in 2023, then jumped by 112.44% to $25.0 million in 2024, then plunged by 900.0% to -$200.0 million in 2025, then grew by 28.0% to -$144.0 million in 2026.
- Per Business Quant, the three latest A Cash from Financing Activities figures stand at -$144.0 million (Q2 2026), -$222.0 million (Q1 2026), and -$200.0 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -144.00 Mn |
| Apr 30, 2026 | -144.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Jan 31, 2024 | -240.00 Mn |
| Jan 31, 2024 | -240.00 Mn |